CHRM1 and diabetic neuropathy: To confirm this neuritogenic pathway was relevant in the setting of diabetic neuropathy, sensory neuron cultures were prepared from a 3–5-month-old STZ-diabetic rat and exposed to the specific M1R antagonist MT7 at 100 nM, with/without 1 μM STO-609 for 24 h.